|
Tony Hunter is one of the foremost leaders in the field of cell growth control, growth factor receptors and signal transduction pathways and has conducted pioneering work in the study of protein-tyrosine kinases and their role in cell growth, oncogenesis and the cell cycle. His research has earned him the prestigious Landon-AACR Prize for Cancer Research, the largest prize offered to cancer researchers from a professional society of their peers. Hunter holds an American Cancer Society Professorship, is a Foreign Associate of the National Academy, and serves on a number of scientific review and advisory committees. He previously founded Signal Pharmaceuticals. Hunter earned his Ph.D. and B.A. from the University of Cambridge, England. | 